Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Suven Pharmaceuticals has informed that the Company has received intimation from shareholder of the Company, regarding loss of share certificate(s) as details enclosed. An email request received from Shareholder is enclosed. The Company is in process of issuing ‘Letter of Confirmation’ in lieu of the original share certificate(s), after completion of required formalities.
The above information is a part of company’s filings submitted to BSE.
